Process for the diagnostic assessment and monitoring, as well as medicaments for the therapy of states of shock in humans
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 23, 2000
Grant Date -
N/A
app pub date -
Jun 3, 1997
filing date -
Oct 12, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method is provided for detecting shock by measuring the concentration of cyclophilins in a patient's blood and comparing the measured concentration against a control. The severity of shock is then evaluated, an increase in cyclophilin concentrations over control levels being associated with severity. Measuring methods include enzymological techniques, such as rotomase activity assay; immunological procedures, such as radioimmunoassay and ELISA; peptide chemical processes, such as affinity chromatography; and radiochemical approaches, such as contacting the sample with radioactive cyclosporin.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully